Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

A retrospective chart review of patients with persistent subretinal and/or intraretinal fluid, despite previous treatment with intravitreal ranibizumab (0.5 mg), who were switched to aflibercept injections, was performed. Treatment was three monthly aflibercept (2 mg) injections followed by dosing o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gharbiya, Magda, Iannetti, Ludovico, Parisi, Francesco, De Vico, Umberto, Mungo, Maria Laura, Marenco, Marco
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2014
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033502/
https://ncbi.nlm.nih.gov/pubmed/24895562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/273754
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares